Growing urbanisation and increased hygiene awareness in developing countries may further aid candidiasis market expansion.
Market Overview
Due to an increase in the number of patients affected by candidiasis infection, an increase in the susceptible immune-compromised patient pool, and increased awareness for candidiasis infection, the candidiasis market is predicted to grow rapidly.
In emerging regions, there has been an increase in the number of patients infected with candidiasis, which may improve total market growth during the forecast period. In the United States, the Centers for Disease Control and Prevention (CDC) estimates that 46,000 cases of healthcare-associated invasive candidiasis occur each year. According to the CDC, people with HIV have a 30-day all-cause (crude) mortality among people with candidemia is approximately 30%. However, because persons who develop invasive candidiasis often have pre-existing medical issues, it's difficult to say how many deaths are directly related to the infection. This increase in the number of patients has aided in the overall market's expansion. Growing urbanisation and increased hygiene awareness in developing countries may further aid market expansion.
Key Market Trends
During the forecast period, Systemic Candidiasis in the Anatomy Type Segment is expected to dominate the market.The rise in the number of immune-compromised patients driving the market for systemic candidiasis. Thrush affects about 2-5 percent of healthy babies and primarily affects them during their first year of life. In the United States, around 1 million adult women and adolescent girls get vaginal yeast infections each year. As a result, during the projection period, the high incidence rate of candidiasis is expected to remain a primary driver of market growth.
Comments
Post a Comment